Skip to main content
Premium Trial:

Request an Annual Quote

MDS Sciex Revenues Slip 4 Percent in Fiscal Q1 as Earnings Slide

NEW YORK, March 9 (GenomeWeb News) - MDS today reported that instrument sales during its fiscal first quarter declined 4 percent to $71 million from $74 million for the year-ago period.

 

Profits for MDS Sciex also fell to $19 million from $21 million in the first quarter of 2005, a 9.5-percent decline. The company said the decrease was "principally due to currency."

 

MDS said that the best-selling products in its Sciex unit were the API 5000, the 4800 MALDI/Tof/TOF, and the 3200 Qtrap. MDS Sciex shipped the first CellKey system produced at the new Singapore facility in the quarter.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.